Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-27, Stock:PFE, The news for the past five days is as follows:
2020-11-19: NEWS1: COVID-19 is ‘very real,’ not a hoax: ER Doctor.NEWS2: Uniqure Hits Pay Dirt In Gene Therapy And The Biotech Stock Bounds Higher.NEWS3: BioNTech CEO Says Coronavirus Vaccine Could Be Home For Christmas.NEWS4: ‘The vaccines are going to bail us out of this:’ INmune Bio CEO on treatment demand amid pandemic.NEWS5: What Lies Ahead for Pfizer ETFs After Another Round of Upbeat Vaccine Data.NEWS6: ApiJect gets $590 mln U.S. loan to produce COVID-19 vaccine injections.NEWS7: Doctor on school closings: 'Let’s make sure we’re closing the highest risk things first'.NEWS8: Oil Prices Fail To Rally Despite A Flurry Of Bullish News.NEWS9: Coronavirus update: U.S. coronavirus deaths surpass 250,000, and hospitalizations reach another record.NEWS10: VBI Vaccines' (VBIV) Early Data on HBV Candidate Positive.NEWS11: COVID Vaccine Logistics To Start As Sprint, Turn  Into Marathon.NEWS12: It’s ‘extremely urgent’ Congress passes another stimulus bill to help hospitals: CEO.NEWS13: Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%.NEWS14: Vaccines Fight Covid, But Can They Stop the Spread?.NEWS15: Major Indices Fall Despite Positive Coronavirus Vaccine Data.NEWS16: Fear and Greed Paralyze Markets as Traders Seek Next Trigger.NEWS17: Trump blocking Biden team from accessing coronavirus data is 'criminal': ex-HHS secretary.NEWS18: Oil Near $44 With Tighter Virus Measures, OPEC+ Cracks Appearing.NEWS19: Gold Miner ETFs Discover Key Chart Support.NEWS20: The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway.NEWS21: What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?.NEWS22: A Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should Know.NEWS23: Results from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine.NEWS24: Vaccines Prove U.S. Is Still Capable of Big Accomplishments.NEWS25: Oxford Study Confirms Astra Covid Shot’s Response in Elderly.NEWS26: EU warns Hungary against use of Russia's COVID-19 vaccine.NEWS27: Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?.NEWS28: What Winning the Covid-19 War Would Look Like.NEWS29: Wall Street Opens Lower as Virus Numbers, Jobless Weigh; Dow Down 120 Pts.NEWS30: Philippines' Duterte agrees to pay for vaccines in advance to ensure supply.NEWS31: COVID-19 Vaccine Update – The Numbers are Impressive but the Markets Need More.NEWS32: Turkey to buy 20 mln COVID-19 vaccine doses from China, also talking to Pfizer.NEWS33: Panama greenlights funds to buy AstraZeneca's planned coronavirus vaccine.NEWS34: GLOBAL MARKETS-Asia stocks ease from highs, bonds count on Fed support.NEWS35: GLOBAL MARKETS-Asian shares fall as fresh outbreaks overshadow vaccine progress.
2020-11-20: NEWS1: FDA panel to discuss emergency use of Pfizer COVID-19 vaccine on Dec. 10.NEWS2: Pfizer, BioNTech make it official: COVID-19 vaccine EUA submitted.NEWS3: US STOCKS-Wall Street closes lower as surging COVID-19 cases offset vaccine hopes.NEWS4: U.S. sees spike in daily COVID-19 cases, hospitalizations surge.NEWS5: US Stock Market Overview – Stock Close Mixed; JP Morgan Forecasts Contraction in Q1.NEWS6: Maravai IPO Raises $1.62 Billion For Provider Of Drug-Testing Services.NEWS7: BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA.NEWS8: Biggest risk to markets is volatility: Expert.NEWS9: Pfizer eyes rapid COVID-19 vaccine roll-out in Latam after U.S. go-ahead.NEWS10: Trump administration will 'likely bungle' COVID-19 vaccine distribution: Doctor.NEWS11: Stock Market Today With Jim Cramer: Avoid Vaccine Stocks.NEWS12: REFILE-US STOCKS-S&P 500, Dow dip as spiking COVID-19 infections eclipse vaccine hopes.NEWS13: Gold Jumps as Mnuchin Says Treasury, Fed Have Plenty of Capacity.NEWS14: Dow Ends Off 220; Stocks Mostly Lower for Week on Covid Surge.NEWS15: Dow Tumbles Amid Treasury's Rift With Fed Over Lending Programs.NEWS16: Remdesivir’s Failure Is a Warning for Covid-19 Vaccines.NEWS17: Maravai LifeSciences Jumps Nearly 19% in IPO, While Sotera Pops 17%.NEWS18: U.S. moves closer to 200,000 daily COVID cases; Birx and Fauci urge Americans to follow safety measures over Thanksgiving.NEWS19: Jim Cramer Says Politics Creating 'Complete Chaos' for Stock Market.NEWS20: US STOCKS-S&P 500, Dow dip on concerns over rising COVID-19 infections.NEWS21: Dow Jones Lags As Market Rally Pauses; Nasdaq On Track For Weekly Gain.NEWS22: Maravai LifeSciences, Sotera Are Slated to Trade Today.NEWS23: UK asks regulator to assess Pfizer vaccine for suitability.NEWS24: Stocks Fall on Treasury's Move Allowing Emergency Fed Programs to Expire.NEWS25: Why Pfizer and BioNTech Stocks Rose Today.NEWS26: U.S. officials worry about holiday spike as coronavirus surges.NEWS27: Moderna, Pfizer having similar efficacies is ‘quite encouraging’: Doctor on vaccine progress.NEWS28: Pfizer and BioNTech Will Ask the FDA to Authorize Their Coronavirus Vaccine Today.NEWS29: Coronavirus update: U.S. moves closer to 200,000 cases a day; Birx and Fauci urge Americans to follow safety measures over Thanksgiving.NEWS30: LIVE: Jim Cramer on Fed, Mnuchin, Politics, What It Means for Stock Market.NEWS31: WHO advises against using Remdesivir to treat COVID-19.NEWS32: US STOCKS-Wall St dips on concerns over fading stimulus, virus fears.NEWS33: Institut Pasteur to keep working on three COVID-19 vaccines.NEWS34: Dow Jones Today, Stocks Dip As Pfizer Seeks Vaccine Approval; BioNTech, Williams-Sonoma Top Buy Points.NEWS35: Pfizer, BioNTech file for emergency use authorization for COVID-19 vaccine.NEWS36: Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More.NEWS37: Pfizer Files For Emergency FDA Approval For COVID Vaccine, Says Can Distribute in December.NEWS38: Pfizer and BioNTech Are Filing Today to Distribute Their Covid-19 Vaccine.NEWS39: It May Be Time To Invest in Emerging Market Value Stocks.  Here’s Where to Look..NEWS40: Dow Jones Today Dips, Futures Mixed As Pfizer Seeks Vaccine Approval; Retailer Stocks Dominate Early Trade.NEWS41: EOG Resources (EOG) Up 32.8% MTD: What's Behind the Rally?.NEWS42: US STOCKS-S&P 500, Dow set for muted open on concerns over fading stimulus.NEWS43: California to Begin Overnight Lockdown.NEWS44: Stock-index futures trade mixed as COVID restrictions threaten recovery.NEWS45: FOREX-Dollar set for weekly loss; risk sentiment still buoyed by vaccine progress.NEWS46: Warren Buffett Just Bought These Stocks.NEWS47: Pfizer Asked the FDA to Approve Its Covid Vaccine. What Comes Next..NEWS48: Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today.NEWS49: BioNTech, Pfizer say they plan to submit COVID-19 vaccine application on Friday.NEWS50: Pfizer is first to apply for U.S. emergency use for COVID-19 vaccine.NEWS51: Pfizer to submit U.S. emergency use application for COVID-19 vaccine.NEWS52: Why Is Everyone Talking About BioNTech Stock?.NEWS53: Doctor and Pandemic Expert Shares What Investors Need To Know About Coronavirus Vaccines.NEWS54: Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine.NEWS55: Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna.NEWS56: Coronavirus update: Pfizer/BioNTech file for emergency vaccine use as WHO hits Gilead's remdesivir.NEWS57: U.S. Futures Mixed; Vaccine News Helps Balance Treasury/Fed Spat.NEWS58: Norwegian Air Shuttle Flew Too Close to the Sun.NEWS59: Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines - source.NEWS60: StockBeat: Surge, Schmurge: The Rotation Trade Is Intact.NEWS61: Pfizer Expected To File For FDA Emergency Approval on Friday, Followed Closely By Moderna, Azar Says.NEWS62: Pfizer/BioNTech vs. Moderna: Which Covid-19 Vaccine Has the Upper Hand?.
2020-11-23: NEWS1: Too Early to Call BioNTech the Winner in the COVID-19 Vaccine Race, Says Analyst.NEWS2: Oil up on Vaccine Positivity, U.S. Electoral Transition Certainty.NEWS3: Oil Stocks Are Finally Bouncing Back.NEWS4: Asian Stocks Up Over Progress on Biden Transition, COVID-19 Vaccine.NEWS5: Fears of a COVID-inspired crude oil glut? Fading ‘contango’ tells a different story.NEWS6: AstraZeneca Dives On Covid Vaccine News, Buoying Moderna, BioNTech.NEWS7: BNP Paribas' Mark Howard on his 2021 market outlook.NEWS8: 'We still have a major problem with outpatient testing': Dr. Amesh Adalja.NEWS9: Doctor: ‘It’s probably going to be springtime’ before general public gets COVID-19 vaccine.NEWS10: A successful Ebola vaccine delivery shows how a Covid-19 vaccine would work in Africa.NEWS11: How Good Is AstraZeneca's Vaccine News?.NEWS12: AstraZeneca Shares Dip Over 3% After COVID-19 Vaccine Proves 70% Effective as Against Rivals.NEWS13: Astra-Oxford Vaccine Found Effective in Preventing Covid.NEWS14: U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections.NEWS15: 3 Dividend Stocks Gurus Like.NEWS16: Regeneron Is Allowed to Sell the Covid Antibody It Served Trump and the Stock Is Rising.NEWS17: AstraZeneca, Oxford Say Cheap, Easy to Store Vaccine Is Up to 90% Effective.NEWS18: With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?.NEWS19: Dow Jones Today, Stocks Open Higher; Merck, Regeneron Jump On Covid News; Tesla Nails A Breakout.NEWS20: Moderna Chief Sells More Shares Ahead of Key Vaccine Filing.NEWS21: Here’s When the First Americans Could Get a Coronavirus Vaccine.NEWS22: Vaccines Are Coming Soon. Is It Time to Sell Stay-at-Home Stocks?.NEWS23: AstraZeneca COVID Vaccine Hits 90% Efficacy in Some Doses.NEWS24: Dow Jones Today Leads Futures Higher, Merck Jumps Into Covid Game; Regeneron Treatment Gets FDA Nod.NEWS25: Your DIY Pandemic Projects Are Helping Home Depot (HD).NEWS26: AstraZeneca’s Tests Show a Third Effective Covid-19 Vaccine. What Happens Now?.NEWS27: Could Late-Stage Coronavirus Vaccine Trials Fail?.NEWS28: Pandemic Expert Answers: 'Do You Foresee Challenges with Vaccine Distribution?'.NEWS29: Ask A Virologist: What's The Timeline for Coronavirus Vaccine Distribution?.NEWS30: Thinking About Buying Coronavirus Vaccine Stocks? Watch This First.NEWS31: What Investors Need To Know About Companies Working on Coronavirus Vaccines.NEWS32: COVID-19 Vaccine Update – AstraZeneca Releases Trial Results.NEWS33: U.S. prepares for first COVID-19 shots as another vaccine candidate emerges.NEWS34: 2 Pick-and-Shovel COVID Vaccine Stocks to Watch.NEWS35: Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors.NEWS36: Better Buy: Gilead Sciences vs. Pfizer.NEWS37: Since Getting a 'Shot' of News, the Indexes Have Been Looking Pale.NEWS38: UK medicine regulator will make Pfizer vaccine decision in "shortest time possible".NEWS39: AstraZeneca-Oxford COVID-19 vaccine can be up to 90% effective, late-stage trials show.NEWS40: Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virus.NEWS41: AstraZeneca, Oxford Covid-19 vaccine can be up to 90% effective, late-stage trials show.NEWS42: Wall Street Analysts Say These 5 Stocks Are A Buy As The World Prepares For The Post-COVID-19 Era.NEWS43: Q&A: Where are we in the COVID-19 vaccine race?.NEWS44: Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By February.NEWS45: AstraZeneca study finds its COVID-19 vaccine effective, with one regimen showing 90% efficacy.NEWS46: EM Review: Vaccine Optimism Powered Risk Assets to Weekly Gain.NEWS47: Gold’s Big Question: Can the Bull Market Outlive a Pandemic?.
2020-11-24: NEWS1: Three Events Markets Will Be Watching As 2020 Comes To A Close.NEWS2: Merck Sales Hit Hardest by Pandemic.NEWS3: GE Aviation Can't Hold Out For Coronavirus Vaccines, Eyes More Cuts.NEWS4: Doctor on positive COVID-19 vaccine news: 'We still need to look at all of the data'.NEWS5: Dow 30,000 Optimism Not Matched by Bond Traders.NEWS6: Coronavirus update: HHS puts vaccine distribution in states' power; Wall Street analysts project lifelong vaccine protection.NEWS7: The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer.NEWS8: 'Reflationary trends' are going to continue into 2021: Research Affiliates.NEWS9: Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism.NEWS10: Reinventing Vaccines To Save Lives And The Economy.NEWS11: Pfizer (PFE) Begins Phase III Study on Hemophilia Candidate.NEWS12: How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?.NEWS13: U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record.NEWS14: 3 Coronavirus Vaccine Makers Near Finish Line in November.NEWS15: Gold Under $1800, Overrun By Risk-on Train.NEWS16: Pfizer COVID-19 vaccine could reach Mexico in December, foreign minister says.NEWS17: Write A Prescription For This Pharma ETF.NEWS18: Be Like Buffett and Wager on Pfizer. Here’s How to Do It With Options..NEWS19: Coronavirus vaccine: AstraZeneca could expand US trial to pursue 90% efficacious vaccine.NEWS20: 5 Top-Performing Leveraged ETF Areas of Last Week.NEWS21: Coronavirus Vaccine Stocks: Is There Room For Multiple Winners?.NEWS22: Cyclical Stocks Pop on Vaccine Progress: 5 Solid Buys.NEWS23: Will Moderna's Coronavirus Vaccine Really Change the Game?.NEWS24: Why Now May Be the Time to Buy Health Care Stocks.NEWS25: Most Americans will comparison shop the coronavirus vaccine.NEWS26: What The Flu Shot's History Tells Us About Coronavirus Vaccines.NEWS27: What to Watch for Next in the Coronavirus Vaccine Race.NEWS28: What Investors Need To Know About Pfizer's Coronavirus Vaccine And Ultra-Cold Storage Requirements.NEWS29: Should Pfizer Shareholders Sell Their Viatris Stock?.NEWS30: Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine.NEWS31: Is Boris Johnson's Britain Finally Turning a Corner?.NEWS32: EU drug regulator could rule on COVID-19 vaccines by year end - report.NEWS33: StockBeat: Compass, AO World Make a Picture of the Great Rotation.NEWS34: Dollar Weakens as Biden's Transition Becomes Clearer.
2020-11-25: NEWS1: How a Restructured Pfizer Will Pay Out Its Dividend.NEWS2: How to Invest in a Post-COVID World.NEWS3: CDC may shorten coronavirus quarantine guidelines: WSJ.NEWS4: Moderna Surges Above Buy Point On European Deal For Covid Vaccine.NEWS5: Getting a COVID-19 test ahead of Thanksgiving travel is 'not as good as staying home’: Doctor.NEWS6: Moderna Soars to Record Ahead of Final Covid Vaccine Analysis.NEWS7: Pfizer Stock Moved Markets This Month, But Can it Rally?.NEWS8: Overlook Novavax at the Risk of Incurring an Opportunity Cost.NEWS9: Moderna’s Final Covid Vaccine Results Are Imminent. Billions in Revenue Will Follow, Goldman Says..NEWS10: 3 EV Stocks to Buy as the Sector Charges Up.NEWS11: Trade Zoom with Confidence After This Harsh Correction.NEWS12: It’s Time for iBio Speculators to Consider Something Else.NEWS13: Redfield: CDC will have shortened quarantine guidelines in a week.NEWS14: The Top 5 Telehealth Stocks Disrupting the Healthcare Sector.NEWS15: Hospital workers called exhausted as U.S. records highest number of COVID deaths since May.NEWS16: COVID-19 is the ‘silent pandemic’, this surge is not like last spring: Robert Redfield.NEWS17: Bears Hold an Edge Ahead of Zoom (ZM) Earnings Report.NEWS18: Coronavirus update: CDC to decrease quarantine time; UPS ramps up dry ice production.NEWS19: Should Value Investors Pick Pfizer (PFE) Stock Right Now?.NEWS20: Equillium's stock tumbles after decision to not initiate late-stage trial of COVID-19 treatment.NEWS21: Thanksgiving Brings Strong Seasonal Market Trends: 5 Picks.NEWS22: U.S. loans $1.1 billion to Ginkgo Bioworks for pandemic effort.NEWS23: Dow Hits 30K for First Time: 7 Stocks Driving the ETF Rally.NEWS24: U.S loans $1.1 bln to Ginkgo Bioworks for pandemic effort.NEWS25: Here's How the Top 3 Coronavirus Vaccine Candidates Stack Up.NEWS26: Warp Speed for Clean Energy? That Won't Work.NEWS27: Could AstraZeneca's Coronavirus Vaccine Beat Pfizer and Moderna?.NEWS28: Better Coronavirus Stock: Pfizer or Moderna?.NEWS29: EXPLAINER-When and how will COVID-19 vaccines become available?.NEWS30: 6.4M Pfizer COVID-19 Vaccine Doses To Be Distributed Across US Within 24 Hours Of FDA Approval: WaPo.

Answer: Rise